Home / Cannapacific Is Pleased To Welcome Tim Bowser

Cannapacific Is Pleased To Welcome Tim Bowser

You can download this article as .pdf

  • Tim Bowser joins the CannaPacific team as the Chief Scientific Officer
  • CannaPacific is attracting great talent to the team with the addition of Tim Bowser as our new Chief Scientific Officer.

14 November 2019 – CannaPacific is pleased to announce the appointment of Tim Bowser as Chief Scientific Officer. Tim heads up the scientific operations of CannaPacific, drawing experience from his recent role as the Head of Australian Operations and R&D for Sun Pharmaceutical Industries – Australia’s Controlled Substances Division.

With over 35 years experience in the pharmaceutical industry, and 25 years in controlled substances  as Site Director for Sun Pharma’s Controlled Substances as well as in Business Development, Operations and Quality, Tim is highly experienced in genomic-based molecular breeding of medicinal plants for the production of pharmaceutical actives.

Tim’s professional qualifications include a Bachelor of Applied Science (Chemistry) from Central Queensland University; Master of Science Qualifier – Natural Products at Deakin University; and an Honorary Fellow from the University of Melbourne. 

During his career Tim has led a major capital expansion program of over A$70million including a Fine Chemicals manufacturing plant (Finalist Australian Engineering Excellence Awards) and A$20million Natural product extraction facility. 

Tim recently completed a stint as an Industrial Placement Fellow at the University of York overseeing a range of new technology projects applying Molecular biology and genetics to plant breeding for High Value Chemicals from Plants, large scale extraction technology as well as applications of Industrial Biotechnology in pharmaceutical actives manufacture.

————————————————————————————————————————————————————

About CannaPacific:
CannaPacific is an Australian biotechnology company focused on the cannabinoid pharmaceutical sector. By combining advanced molecular breeding technology with a traditional approach to drug development CannaPacific seeks to build a global therapeutic offering with an initial focus on palliative care and post traumatic stress disorder.

CannaPacific’s strategy is to attain a world-leading position in the field of cannabinoid science through the research, development and commercialisation of cannabinoid molecules as authorised pharmaceutical products.

About medicinal cannabis:
Governments at both Commonwealth and State and Territory levels have implemented legislative and policy change to allow the cultivation, manufacture, prescribing and dispensing of medicinal cannabis products for patients in Australia. https://www.tga.gov.au/medicinal-cannabis-guidance-documents

Contact:
Joshua Dennis (CEO
josh@cannapacific.com.au
Ph: 0427 631 611 

Request Info

Enquire now

Request Info